Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7384)
All Articles published online
|
Jan 28, 2011 (publication date) through Jan 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Giouleme O, Diamantidis MD, Katsaros MG. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms. World J Gastroenterol 2011; 17(4): 444-448 [PMID: 21274373 DOI: 10.3748/wjg.v17.i4.444] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i4/444.htm |
| Number | Citing Articles |
| 1 |
Po-Ke Hsu, Jing-Yang Huang, Wei-Wen Su, James Cheng-Chung Wei. Type 2 diabetes and the risk of colorectal polyps. Medicine 2021; 100(19): e25933 doi: 10.1097/MD.0000000000025933
|
| 2 |
Kazuya Hata, Masaya Kubota, Masahito Shimizu, Hisataka Moriwaki, Toshiya Kuno, Takuji Tanaka, Akira Hara, Yoshinobu Hirose. C57BL/KsJ-db/db-ApcMin/+ Mice Exhibit an Increased Incidence of Intestinal Neoplasms. International Journal of Molecular Sciences 2011; 12(11): 8133 doi: 10.3390/ijms12118133
|
| 3 |
Maria Kasdagly, Sridhar Radhakrishnan, Lavanya Reddivari, D.N. Rao Veeramachaneni, Jairam Vanamala. Colon carcinogenesis: Influence of Western diet-induced obesity and targeting stem cells using dietary bioactive compounds. Nutrition 2014; 30(11-12): 1242 doi: 10.1016/j.nut.2014.02.016
|
| 4 |
M. Makov, G. Chodick, K. Mohnike, T. Otonkoski, H. Huopio, I. Banerjee, H. Cave, M. Polak, H. T. Christesen, K. Hussain, D. Deleon, C. Stanley, M. Cappa, O. Ramos, D. Zangen, Z. Laron. Congenital hyperinsulinism, neonatal diabetes and the risk of malignancies: an international collaborative study. Preliminary communication. Diabetic Medicine 2015; 32(5): 701 doi: 10.1111/dme.12670
|
| 5 |
Hsin-En Huang, Yi-Ching Yang, Jin-Shang Wu, Ru-Hsueh Wang, Feng-Hwa Lu, Chih-Jen Chang. The relationship between different glycemic statuses and colon polyps in a Taiwanese population. Journal of Gastroenterology 2014; 49(7): 1145 doi: 10.1007/s00535-013-0863-5
|
| 6 |
Saumitra Gajjar, Vivek Bora, Bhoomika M. Patel. Repositioning of simvastatin for diabetic colon cancer: role of CDK4 inhibition and apoptosis. Molecular and Cellular Biochemistry 2023; 478(10): 2337 doi: 10.1007/s11010-023-04663-w
|
| 7 |
G. E. C. Sun, B. J. Wells, K. Yip, R. Zimmerman, D. Raghavan, M. W. Kattan, S. R. Kashyap. Gender‐specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 2014; 16(3): 276 doi: 10.1111/dom.12231
|
| 8 |
Dinesh Vyas, Chad C. Garthe, Arpita Vyas. Limitations of Current Timing and Frequency of Screening Colonoscopy and Possible Future Direction. Journal of Laparoendoscopic & Advanced Surgical Techniques 2013; 23(3): 271 doi: 10.1089/lap.2012.0428
|
| 9 |
Fatima Mohsen Mroueh, Mohamed Noureldein, Youssef H. Zeidan, Suzan Boutary, Sara Abou Merhi Irani, Stéphanie Eid, Mary Haddad, Rasha Barakat, Frederic Harb, Joseph Costantine, Rouwaida Kanj, Erik‐Andre Sauleau, Allal Ouhtit, Sami T. Azar, Ali H. Eid, Assaad A. Eid. Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer. The FASEB Journal 2019; 33(12): 14051 doi: 10.1096/fj.201900396RR
|
| 10 |
Jessica K. Paulus, Christina D. Williams, Furha I. Cossor, Michael J. Kelley, Robert E. Martell. Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention 2016; 25(10): 1418 doi: 10.1158/1055-9965.EPI-16-0312
|
| 11 |
Guan-Hua Yu, Shuo-Feng Li, Ran Wei, Zheng Jiang, Eusebio Chiefari. Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications. Journal of Diabetes Research 2022; 2022: 1 doi: 10.1155/2022/1747326
|
| 12 |
Patrizia Ferroni, Vincenzo Formica, David Della-Morte, Jessica Lucchetti, Antonella Spila, Roberta D'Alessandro, Silvia Riondino, Fiorella Guadagni, Mario Roselli. Prognostic value of glycated hemoglobin in colorectal cancer. World Journal of Gastroenterology 2016; 22(45): 9984-9993 doi: 10.3748/wjg.v22.i45.9984
|
| 13 |
Doran Avivi, Menachem Moshkowitz, Elmar Detering, Nadir Arber. The role of low-dose aspirin in the prevention of colorectal cancer. Expert Opinion on Therapeutic Targets 2012; 16(sup1): S51 doi: 10.1517/14728222.2011.647810
|
| 14 |
Hsiuying Wang. MicroRNA, Diabetes Mellitus and Colorectal Cancer. Biomedicines 2020; 8(12): 530 doi: 10.3390/biomedicines8120530
|
| 15 |
A Vasconcelos-dos-Santos, H F B R Loponte, N R Mantuano, I A Oliveira, I F de Paula, L K Teixeira, J C M de-Freitas-Junior, K C Gondim, N Heise, R Mohana-Borges, J A Morgado-Díaz, W B Dias, A R Todeschini. Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway. Oncogenesis 2017; 6(3): e306 doi: 10.1038/oncsis.2017.2
|
| 16 |
Zhuoyu Sun, Lin Liu, Peizhong Peter Wang, Barbara Roebothan, Jin Zhao, Elizabeth Dicks, Michelle Cotterchio, Sharon Buehler, Peter T Campbell, John R Mclaughlin, Patrick S Parfrey. Association of total energy intake and macronutrient consumption with colorectal cancer risk: results from a large population-based case-control study in Newfoundland and Labrador and Ontario, Canada. Nutrition Journal 2012; 11(1) doi: 10.1186/1475-2891-11-18
|
| 17 |
Marc Rendell, Halis Kaan Akturk, Sri Harsha Tella. Glargine safety, diabetes and cancer. Expert Opinion on Drug Safety 2013; 12(2): 247 doi: 10.1517/14740338.2013.770469
|
| 18 |
Michael Erbach, Hellmut Mehnert, Oliver Schnell. Diabetes and the risk for colorectal cancer. Journal of Diabetes and its Complications 2012; 26(1): 50 doi: 10.1016/j.jdiacomp.2011.11.003
|
| 19 |
Yiping Cheng, Junming Han, Qihang Li, Yingzhou Shi, Fang Zhong, Yafei Wu, Zhixiang Wang, Zhongshang Yuan, Xiude Fan, Jiajun Zhao. Metabolic obesity phenotypes: a friend or foe of digestive polyps?—An observational study based on National Inpatient Database. Metabolism 2022; 132: 155201 doi: 10.1016/j.metabol.2022.155201
|
| 20 |
Carmine Finelli, Giovanni Tarantino. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?. Hepatology International 2013; 7(2): 413 doi: 10.1007/s12072-012-9406-z
|
| 21 |
Mehulkumar K. Kanadiya, Tushar D. Gohel, Madhusudhan R. Sanaka, Prashanthi N. Thota, Jay H. Shubrook. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy. Journal of Diabetes and its Complications 2013; 27(5): 463 doi: 10.1016/j.jdiacomp.2013.04.010
|
| 22 |
Vinicius Kannen, Sergio Britto Garcia, Helga Stopper, Ana Maria Waaga-Gasser. Glucagon-like peptide 2 in colon carcinogenesis: Possible target for anti-cancer therapy?. Pharmacology & Therapeutics 2013; 139(1): 87 doi: 10.1016/j.pharmthera.2013.04.007
|
| 23 |
Kruti Patel, Vivek Bora, Bhoomika Patel. Sodium orthovanadate exhibits anti-angiogenic, antiapoptotic and blood glucose-lowering effect on colon cancer associated with diabetes. Cancer Chemotherapy and Pharmacology 2024; 93(1): 55 doi: 10.1007/s00280-023-04596-7
|
| 24 |
Ian N. Hines, Hadley J. Hartwell, Yan Feng, Elizabeth J. Theve, Gregory A. Hall, Sara Hashway, Jessica Connolly, Michelle Fecteau, James G. Fox, Arlin B. Rogers. Insulin Resistance and Metabolic Hepatocarcinogenesis with Parent-of-Origin Effects in A×B Mice. The American Journal of Pathology 2011; 179(6): 2855 doi: 10.1016/j.ajpath.2011.08.014
|
| 25 |
O. Yu. Kolesnichenko, Yu. Yu. Kolesnichenko, V. V. Pulit, A. V. Martynov, A. Yu. Sotnik, I. A. Khaykina, E. B. Marochkina, L. O. Minushkina, K. V. Pimenova, A. S. Bugakova, E. Yu. Vasilyeva, R. N. Komarov, A. V. Golovanov. Big Data Analytics of EHRs: pathogenic relations of cancer with Ischaemic Heart Disease and Diabetes Mellitus. Remedium 2019; (12): 36 doi: 10.21518/1561-5936-2019-12-36-43
|
| 26 |
Jinming Xu, Yao Ye, Han Wu, Penelope Duerksen-Hughes, Honghe Zhang, Peiwei Li, Jian Huang, Jun Yang, Yihua Wu, Dajing Xia. Association between markers of glucose metabolism and risk of colorectal cancer. BMJ Open 2016; 6(6): e011430 doi: 10.1136/bmjopen-2016-011430
|
| 27 |
K. Hata, M. Kubota, M. Shimizu, H. Moriwaki, T. Kuno, T. Tanaka, A. Hara, Y. Hirose. Monosodium glutamate-induced diabetic mice are susceptible to azoxymethane-induced colon tumorigenesis. Carcinogenesis 2012; 33(3): 702 doi: 10.1093/carcin/bgr323
|
| 28 |
Aminat O. Oluyemi, Amy R. Welch, Lisa J. Yoo, Erik B. Lehman, Thomas J. McGarrity, Cynthia H. Chuang. Colorectal cancer screening in high‐risk groups is increasing, although current smokers fall behind. Cancer 2014; 120(14): 2106 doi: 10.1002/cncr.28707
|
| 29 |
Tomas Grega, Gabriela Vojtechova, Monika Gregova, Miroslav Zavoral, Stepan Suchanek. Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia. Physiological Research 2021; : 509 doi: 10.33549/physiolres.934631
|
| 30 |
J.‐P. Feng, X.‐L. Yuan, M. Li, J. Fang, T. Xie, Y. Zhou, Y.‐M. Zhu, M. Luo, M. Lin, D.‐W. Ye. Secondary diabetes associated with 5‐fluorouracil‐based chemotherapy regimens in non‐diabetic patients with colorectal cancer: results from a single‐centre cohort study. Colorectal Disease 2013; 15(1): 27 doi: 10.1111/j.1463-1318.2012.03097.x
|
| 31 |
Keishi Sugimachi, Rui Yamaguchi, Hidetoshi Eguchi, Masami Ueda, Atsushi Niida, Shotaro Sakimura, Hidenari Hirata, Ryutaro Uchi, Yoshiaki Shinden, Tomohiro Iguchi, Kazutoyo Morita, Ken Yamamoto, Satoru Miyano, Masaki Mori, Yoshihiko Maehara, Koshi Mimori. 8q24 Polymorphisms and Diabetes Mellitus Regulate Apolipoprotein A-IV in Colorectal Carcinogenesis. Annals of Surgical Oncology 2016; 23(S4): 546 doi: 10.1245/s10434-016-5374-1
|
| 32 |
Mayur M. Patel, Bhoomika M. Patel. Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition. European Journal of Pharmaceutical Sciences 2018; 121: 188 doi: 10.1016/j.ejps.2018.05.026
|
| 33 |
Hyun-Kyung Chung. Letter: The Association between Type 2 Diabetes Mellitus and Colorectal Cancer. Endocrinology and Metabolism 2011; 26(4): 364 doi: 10.3803/EnM.2011.26.4.364
|
| 34 |
Rui Sun, Jian-Ping Liu, Chang Gao, Ying-Ying Xiong, Min Li, Ya-Ping Wang, Yan-Wei Su, Mei Lin, An-Li Jiang, Ling-Fan Xiong, Yan Xie, Jue-Ping Feng. Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population. Oncotarget 2016; 7(20): 29770 doi: 10.18632/oncotarget.8865
|
| 35 |
Junichi Kato, Yohei Shirakami, Masahito Shimizu. Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs. Gastrointestinal Disorders 2019; 1(2): 273 doi: 10.3390/gidisord1020023
|
| 36 |
Xiaoshan Feng, Ruirui Xuan, Yingchun Dong, Xiaoqin Wu, Yiping Cheng, Zinuo Yuan, Hang Dong, Junming Han, Fang Zhong, Jiajun Zhao, Xiude Fan. Changes in Clinical Manifestations Due to AFLD Retyping Based on the New MAFLD Criteria: An Observational Study Based on the National Inpatient Sample Database. Diagnostics 2023; 13(3): 488 doi: 10.3390/diagnostics13030488
|
| 37 |
Chin‐Hsiao Tseng. Diabetes and thyroid cancer mortality: a 12‐year prospective follow‐up of Taiwanese. European Journal of Clinical Investigation 2013; 43(6): 595 doi: 10.1111/eci.12086
|
| 38 |
VINCENZA CONTEDUCA, DOMENICO SANSONNO, SABINO RUSSI, FRANCO DAMMACCO. Precancerous colorectal lesions. International Journal of Oncology 2013; 43(4): 973 doi: 10.3892/ijo.2013.2041
|
| 39 |
Jelena Vekic, Aleksandra Zeljkovic, Aleksandra Stefanovic, Rosaria Vincenza Giglio, Marcello Ciaccio, Manfredi Rizzo. Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents. International Journal of Molecular Sciences 2021; 22(22): 12409 doi: 10.3390/ijms222212409
|
| 40 |
Shrimahitha Duraiyarasan, Mayowa Adefuye, Nisha Manjunatha, Vinutna Ganduri, Kruthiga Rajasekaran. Colon Cancer and Obesity: A Narrative Review. Cureus 2022; doi: 10.7759/cureus.27589
|
| 41 |
Chin-Hsiao Tseng. Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan. European Journal of Endocrinology 2012; 167(3): 409 doi: 10.1530/EJE-12-0369
|
| 42 |
Yun Jung Bae, Sung-Eun Kim, Seong Yeon Hong, Taesun Park, Sang Gyu Lee, Myung-Sook Choi, Mi-Kyung Sung. Time-course microarray analysis for identifying candidate genes involved in obesity-associated pathological changes in the mouse colon. Genes & Nutrition 2016; 11(1) doi: 10.1186/s12263-016-0547-x
|
| 43 |
Anurag Sharma, Hanyann Ng, Abhishek Kumar, Kunal Teli, Jeewanjot Randhawa, James Record, Michael Maroules. Colorectal Cancer: Histopathologic Differences in Tumor Characteristics Between Patients With and Without Diabetes. Clinical Colorectal Cancer 2014; 13(1): 54 doi: 10.1016/j.clcc.2013.10.002
|
| 44 |
Thomas Broughton, Jamie Sington, Ian L. P. Beales. Statin use is associated with a reduced incidence of colorectal adenomatous polyps. International Journal of Colorectal Disease 2013; 28(4): 469 doi: 10.1007/s00384-012-1601-9
|
| 45 |
祥政 孟. Research Progress on the Relationship between Type 2 Diabetes Mellitus and Colorectal Adenomas. World Journal of Cancer Research 2024; 14(02): 88 doi: 10.12677/wjcr.2024.142013
|
| 46 |
Shaun V. Walsh, Frank A. Carey. Morson and Dawson's Gastrointestinal Pathology. 2013; : 685 doi: 10.1002/9781118399668.ch38
|
| 47 |
Jingjing Wu, Huimin He, Qi Zhang, Yan Zhang. Fasting blood glucose was linearly associated with colorectal cancer risk in the population without self-reported diabetes mellitus history. Medicine 2021; 100(34): e26974 doi: 10.1097/MD.0000000000026974
|
| 48 |
Justin Y. Jeon, Duck Hyoun Jeong, Min Geun Park, Ji-Won Lee, Sang Hui Chu, Ji-Hye Park, Mi Kyung Lee, Kaori Sato, Jennifer A. Ligibel, Jeffrey A. Meyerhardt, Nam Kyu Kim, Antonio Moschetta. Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal Cancer. PLoS ONE 2013; 8(2): e55196 doi: 10.1371/journal.pone.0055196
|
| 49 |
Hans J. Nielsen, Karen V. Jakobsen, Ib J. Christensen, Nils Brünner. Screening for colorectal cancer: possible improvements by risk assessment evaluation?. Scandinavian Journal of Gastroenterology 2011; 46(11): 1283 doi: 10.3109/00365521.2011.610002
|
| 50 |
E. A. Lapteva, A. P. Bykova. Structural and functional features of the colon in patients with non-alcoholic fatty liver disease and comorbid pathology. Experimental and Clinical Gastroenterology 2022; (3): 37 doi: 10.31146/1682-8658-ecg-199-3-37-42
|
| 51 |
Shahzaib Ahmad, Tahseen A. Chowdhury, Barbara J. Boucher. Diabetes and cancer: Could vitamin D provide the link?. Journal of Diabetes and its Complications 2013; 27(2): 184 doi: 10.1016/j.jdiacomp.2012.10.005
|
| 52 |
I. V. Druk, E. A. Lyalyukova, E. A. Fadeeva. Metformin in the prevention of colorectal cancer with diabetes mellitus. Experimental and Clinical Gastroenterology 2022; (9): 161 doi: 10.31146/1682-8658-ecg-205-9-161-170
|
| 53 |
Sergio Ruiz-Saavedra, Nuria Salazar, Adolfo Suárez, Ylenia Diaz, Carmen González del Rey, Sonia González, Clara G. de los Reyes-Gavilán. Human fecal alpha-glucosidase activity and its relationship with gut microbiota profiles and early stages of intestinal mucosa damage. Anaerobe 2024; 87: 102853 doi: 10.1016/j.anaerobe.2024.102853
|
| 54 |
Zhang Jiaqi, Seung-Hui Choi, Daeun Hong, Tai-sun Shin, Jung-Mi Yun. Sargahydroquinoic Acid from Brown Seaweed Induces Apoptosis in High Glucose Treated-Human Colon Cancer HCT116 Cells. Journal of the Korean Society of Food Science and Nutrition 2024; 53(7): 708 doi: 10.3746/jkfn.2024.53.7.708
|
| 55 |
Robin Myte, Sophia Harlid, Anneli Sundkvist, Björn Gylling, Jenny Häggström, Carl Zingmark, Anna Löfgren Burström, Richard Palmqvist, Bethany Van Guelpen. A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-62129-1
|
| 56 |
HONG CAO, CHUNHUI JIN, DEFANG HUANG, CHAO LIU, DAOQI SUN, CHENG TAN, XIAOMING ZHU, YAJUN FEI. Changes in serum IGF-1 level and tumor VEGF expression in mice with colorectal cancer under hyperglycemic conditions. Molecular Medicine Reports 2013; 7(4): 1361 doi: 10.3892/mmr.2013.1339
|
| 57 |
Saumitra Gajjar, Bhoomika M. Patel. Common targets for a deadly duo of diabetes mellitus and colon cancer: Catching two fish with one worm. European Journal of Pharmacology 2021; 893: 173805 doi: 10.1016/j.ejphar.2020.173805
|
| 58 |
Thomas Broughton, Jamie Sington, Ian LP Beales. Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case–control study. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-36
|
| 59 |
C. C. Lin, M. S. Lai, W. Y. Shau. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population‐based cohort study. Diabetic Medicine 2015; 32(3): 324 doi: 10.1111/dme.12596
|
| 60 |
Harald zur Hausen. Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancer. International Journal of Cancer 2012; 130(11): 2475 doi: 10.1002/ijc.27413
|
| 61 |
Luis A. Garcia Rodriguez, Lucia Cea-Soriano, Stefania Tacconelli, Paola Patrignani. Prospects for Chemoprevention of Colorectal Neoplasia. Recent Results in Cancer Research 2013; 191: 67 doi: 10.1007/978-3-642-30331-9_4
|
| 62 |
Niyati R. Shah, Bhoomika M. Patel. Secoisolariciresinol diglucoside rich extract of L. usitatissimum prevents diabetic colon cancer through inhibition of CDK4. Biomedicine & Pharmacotherapy 2016; 83: 733 doi: 10.1016/j.biopha.2016.07.041
|